Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Illini O, Hund AC, Kopp HG, Moskovitz M, Mountzios G, Brueckl WM, Früh M, Leßmann ME, Christopoulos P, Stenzinger A, Thomas M, Gillis R, Peled N, Acker F, Addeo A, Charpidou A, Grohé C, Hummel HD, Mauti L, Rothschild SI, Schmid S, Schumann C, Urban D, Wurm R, Ekman S, Skribek M, Glanemann F, Wiesweg M, Ackermann CJ, Agelaki S, Hoffknecht P, Jakopović M, Kern J, König D, Kostenzer K, Kropf-Sanchen C, Laack E, Lang D, Nagl L, Pall G, Reck M, Kian W, Allemann AT, Alt J, Araújo D, Bohnenberger H, Bokas A, Fabikan H, Julie KJ, Weinlinger C, Johannes de Langen A, Fergadis EG, Fischer R, Fountzilas E, Froesch P, Frost N, Griesinger F, Jordan F, Karanikiotis C, Kiesewetter B, Korantzis I, Machado AL, Economopoulou P, Pilz A, Reimann P, Rittmeyer A, Saad A, Samitas K, Schulmann K, Shah R, Stratmann JA, Taghizadeh H, Tammoscheit K, Tufman A, Weber JP, Wöll E, Valipour A, Overbeck TR, Hochmair MJ

Open source

DOI
10.1016/j.jtho.2026.103651
Published
2026 Jul
Container
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtho.2026.103651,
  title = {Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.},
  author = {Illini O and Hund AC and Kopp HG and Moskovitz M and Mountzios G and Brueckl WM and Früh M and Leßmann ME and Christopoulos P and Stenzinger A and Thomas M and Gillis R and Peled N and Acker F and Addeo A and Charpidou A and Grohé C and Hummel HD and Mauti L and Rothschild SI and Schmid S and Schumann C and Urban D and Wurm R and Ekman S and Skribek M and Glanemann F and Wiesweg M and Ackermann CJ and Agelaki S and Hoffknecht P and Jakopović M and Kern J and König D and Kostenzer K and Kropf-Sanchen C and Laack E and Lang D and Nagl L and Pall G and Reck M and Kian W and Allemann AT and Alt J and Araújo D and Bohnenberger H and Bokas A and Fabikan H and Julie KJ and Weinlinger C and Johannes de Langen A and Fergadis EG and Fischer R and Fountzilas E and Froesch P and Frost N and Griesinger F and Jordan F and Karanikiotis C and Kiesewetter B and Korantzis I and Machado AL and Economopoulou P and Pilz A and Reimann P and Rittmeyer A and Saad A and Samitas K and Schulmann K and Shah R and Stratmann JA and Taghizadeh H and Tammoscheit K and Tufman A and Weber JP and Wöll E and Valipour A and Overbeck TR and Hochmair MJ},
  year = {2026},
  journal = {Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  doi = {10.1016/j.jtho.2026.103651},
  url = {https://doi.org/10.1016/j.jtho.2026.103651}
}

RIS

TY  - JOUR
TI  - Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
AU  - Illini O
AU  - Hund AC
AU  - Kopp HG
AU  - Moskovitz M
AU  - Mountzios G
AU  - Brueckl WM
AU  - Früh M
AU  - Leßmann ME
AU  - Christopoulos P
AU  - Stenzinger A
AU  - Thomas M
AU  - Gillis R
AU  - Peled N
AU  - Acker F
AU  - Addeo A
AU  - Charpidou A
AU  - Grohé C
AU  - Hummel HD
AU  - Mauti L
AU  - Rothschild SI
AU  - Schmid S
AU  - Schumann C
AU  - Urban D
AU  - Wurm R
AU  - Ekman S
AU  - Skribek M
AU  - Glanemann F
AU  - Wiesweg M
AU  - Ackermann CJ
AU  - Agelaki S
AU  - Hoffknecht P
AU  - Jakopović M
AU  - Kern J
AU  - König D
AU  - Kostenzer K
AU  - Kropf-Sanchen C
AU  - Laack E
AU  - Lang D
AU  - Nagl L
AU  - Pall G
AU  - Reck M
AU  - Kian W
AU  - Allemann AT
AU  - Alt J
AU  - Araújo D
AU  - Bohnenberger H
AU  - Bokas A
AU  - Fabikan H
AU  - Julie KJ
AU  - Weinlinger C
AU  - Johannes de Langen A
AU  - Fergadis EG
AU  - Fischer R
AU  - Fountzilas E
AU  - Froesch P
AU  - Frost N
AU  - Griesinger F
AU  - Jordan F
AU  - Karanikiotis C
AU  - Kiesewetter B
AU  - Korantzis I
AU  - Machado AL
AU  - Economopoulou P
AU  - Pilz A
AU  - Reimann P
AU  - Rittmeyer A
AU  - Saad A
AU  - Samitas K
AU  - Schulmann K
AU  - Shah R
AU  - Stratmann JA
AU  - Taghizadeh H
AU  - Tammoscheit K
AU  - Tufman A
AU  - Weber JP
AU  - Wöll E
AU  - Valipour A
AU  - Overbeck TR
AU  - Hochmair MJ
PY  - 2026
JO  - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
DO  - 10.1016/j.jtho.2026.103651
UR  - https://doi.org/10.1016/j.jtho.2026.103651
ER  -

APA

O, I., AC, H., HG, K., M, M., G, M., WM, B., M, F., ME, L., P, C., A, S., M, T., R, G., N, P., F, A., A, A., A, C., C, G., HD, H., L, M., SI, R., S, S., C, S., D, U., R, W., S, E., M, S., F, G., M, W., CJ, A., S, A., P, H., M, J., J, K., D, K., K, K., C, K., E, L., D, L., L, N., G, P., M, R., W, K., AT, A., J, A., D, A., H, B., A, B., H, F., KJ, J., C, W., A, J. D. L., EG, F., R, F., E, F., P, F., N, F., F, G., F, J., C, K., B, K., I, K., AL, M., P, E., A, P., P, R., A, R., A, S., K, S., K, S., R, S., JA, S., H, T., K, T., A, T., JP, W., E, W., A, V., TR, O., & MJ, H. (2026). Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2026.103651

Source records